Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy
dc.authorid | Saadettin Kılıçkap / 0000-0003-1637-7390 | en_US |
dc.authorscopusid | Saadettin Kılıçkap / 8665552100 | en_US |
dc.authorwosid | Saadettin Kılıçkap / AAP-3732-2021 | en_US |
dc.contributor.author | Yıldırım, H. C. | |
dc.contributor.author | Güven, D. C. C. | |
dc.contributor.author | Aktepe, O. H. | |
dc.contributor.author | Yılmaz, F. | |
dc.contributor.author | Aktaş, B. Y. | |
dc.contributor.author | Güner, G. | |
dc.contributor.author | Dizdar, O. | |
dc.contributor.author | Aksoy, S. | |
dc.contributor.author | Erman, M. | |
dc.contributor.author | Yalçın, S. | |
dc.contributor.author | Kılıçkap, Saadettin | |
dc.date.accessioned | 2022-12-21T08:13:58Z | |
dc.date.available | 2022-12-21T08:13:58Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy | en_US |
dc.identifier.citation | Yildirim, H. C., Guven, D. C. C., Aktepe, O. H., Yilmaz, F., Aktas, B. Y., Guner, G., ... & Kilickap, S. (2022). 773P Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy. Annals of Oncology, 33, S894-S895. | en_US |
dc.identifier.doi | 10.1016/j.annonc.2022.07.899 | en_US |
dc.identifier.endpage | S895 | en_US |
dc.identifier.issn | 0923-7534 | en_US |
dc.identifier.issn | 1569-8041 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.startpage | S894 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1016/j.annonc.2022.07.899 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/3749 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000866211601044 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.institutionauthor | Kılıçkap, Saadettin | |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER | en_US |
dc.relation.ispartof | ANNALS OF ONCOLOGY | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy | en_US |
dc.type | Article | en_US |